EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity
Article first published online: 22 MAY 2007
DOI: 10.1111/j.1398-9995.2007.01409.x
Additional Information
How to Cite
Niżankowska-Mogilnicka, E., Bochenek, G., Mastalerz, L., Świerczyńska, M., Picado, C., Scadding, G., Kowalski, M. L., Setkowicz, M., Ring, J., Brockow, K., Bachert, C., Wöhrl, S., Dahlén, B. and Szczeklik, A. (2007), EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy, 62: 1111–1118. doi: 10.1111/j.1398-9995.2007.01409.x
Publication History
- Issue published online: 18 JUN 2007
- Article first published online: 22 MAY 2007
- Accepted for publication 5 April 2007
- Abstract
- Article
- References
- Cited By
Keywords:
- aspirin;
- aspirin challenge;
- aspirin-induced asthma/rhinitis;
- aspirin-induced urticaria;
- hypersensitivity
Abstract: Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most common causes of adverse drug reactions. Majority of them are of the hypersensitivity type. The two frequent clinical presentations of aspirin hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/angioedema (AIU). The decisive diagnosis is based on provocation tests with aspirin, as the in vitro test does not hold diagnostic value as yet. Detailed protocols of oral, bronchial and nasal aspirin provocation tests are presented. Indications, contraindications for the tests, the rules of drug withdrawal and equipment are reviewed. Patient supervision and interpretations of the tests are proposed.

1398-9995/asset/olbannerleft.gif?v=1&s=2207070238298c1b0c4b1e73fa97140fa65e5f81)
1398-9995/asset/olbannerright.gif?v=1&s=c902da976bf6db24fc36ec0480207615a3d14921)
